- Home
- LNTH vs SIG Comparison
LNTH vs SIG Comparison
Compare LNTH & SIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LNTH | SIG |
|---|---|---|
| Founded | 1956 | 1950 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Consumer Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 3.8B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | LNTH | SIG |
|---|---|---|
| Price | $67.59 | $89.97 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 7 |
| Target Price | $78.00 | ★ $108.14 |
| AVG Volume (30 Days) | ★ 788.1K | 765.8K |
| Earning Date | 02-25-2026 | 12-02-2025 |
| Dividend Yield | N/A | ★ 1.43% |
| EPS Growth | ★ N/A | N/A |
| EPS | 2.39 | ★ 3.42 |
| Revenue | $1,525,933,000.00 | ★ $6,821,100,000.00 |
| Revenue This Year | $0.01 | $2.26 |
| Revenue Next Year | $0.26 | $1.58 |
| P/E Ratio | $28.21 | ★ $26.22 |
| Revenue Growth | ★ 1.95 | N/A |
| 52 Week Low | $47.25 | $45.55 |
| 52 Week High | $111.29 | $110.20 |
Technical Indicators
Market Signals| Indicator | LNTH | SIG |
|---|---|---|
| Relative Strength Index (RSI) | 58.69 | 50.85 |
| Support Level | $63.37 | $92.44 |
| Resistance Level | $67.92 | $96.90 |
| Average True Range (ATR) | 2.06 | 4.17 |
| MACD | -0.37 | 0.65 |
| Stochastic Oscillator | 58.76 | 56.06 |
Price Performance
Historical ComparisonAbout LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About SIG Signet Jewelers Limited
Signet Jewelers Ltd is a retailer of diamond jewelry. Its merchandise mix includes bridal, fashion, watches, and others. The bridal category includes engagement, wedding and anniversary purchases. Its segments are the North America segment, the International segment, and the Other segment. The North America segment contributes to the majority of the revenue. The North America segment generates revenue from Mall and Off-Mall & Outlet.